ValiRx (LSE:VAL) 3-Year Book Growth Rate : -41.10% (As of Jun. 2023)

View and export this data going back to 2000. Start your Free Trial

What is ValiRx 3-Year Book Growth Rate?

ValiRx's Book Value per Share for the quarter that ended in Jun. 2023 was £0.04.

During the past 12 months, ValiRx's average Book Value per Share Growth Rate was 28.10% per year. During the past 3 years, the average Book Value per Share Growth Rate was -41.10% per year. During the past 5 years, the average Book Value per Share Growth Rate was -50.50% per year. During the past 10 years, the average Book Value per Share Growth Rate was -53.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of ValiRx was -20.80% per year. The lowest was -64.40% per year. And the median was -52.05% per year.

Competitive Comparison of ValiRx's 3-Year Book Growth Rate

For the Biotechnology subindustry, ValiRx's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ValiRx's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ValiRx's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where ValiRx's 3-Year Book Growth Rate falls into.

ValiRx 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

ValiRx (LSE:VAL) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

ValiRx 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of ValiRx's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

ValiRx (LSE:VAL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ValiRx PLC (LSE:VAL) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

EAJF:Germany

Address

4 Barling Way, Eliot Park Innovation Centre, Nuneaton, GBR, CV10 7RH

Website

https://www.valirx.com

ValiRx PLC is a UK-based biopharmaceutical company. It mainly engages in developing technologies and products in oncology therapeutics and diagnostics. The area of focus for the company is the treatment of cancer and associated biomarkers, specializing in epigenomic and genetic analysis. The company develops therapeutics across fields in oncology and has a portfolio of products in the pipeline which include GeneICE for Silencing Rebellious Genes, VAL201 for prostate cancer, NAV3 for the cancer screening test, and VAL401 for lung cancer.